ATM, R., D, I., CG, B., R, C., ML, N., F, A., . . . N, L. (2026). Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis. American journal of clinical dermatology, 27(1), 49. https://doi.org/10.1007/s40257-025-00997-x
Chicago Style (17th ed.) CitationATM, Rønnstad, et al. "Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis." American Journal of Clinical Dermatology 27, no. 1 (2026): 49. https://doi.org/10.1007/s40257-025-00997-x.
MLA (9th ed.) CitationATM, Rønnstad, et al. "Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis." American Journal of Clinical Dermatology, vol. 27, no. 1, 2026, p. 49, https://doi.org/10.1007/s40257-025-00997-x.